New cases of vasculitis after alemtuzumab

Mult Scler. 2020 Oct;26(12):1606-1608. doi: 10.1177/1352458520908040. Epub 2020 Feb 21.

Authors

Christina J Azevedo¹, Scott S Zamvil²

Affiliations

¹ Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
² Department of Neurology, University of California-San Francisco, San Francisco, CA, USA.

PMID: 32081067
DOI: 10.1177/1352458520908040

No abstract available

Publication types

Comment

MeSH terms

Alemtuzumab / adverse effects
Antibodies, Antineutrophil Cytoplasmic
Humans
Multiple Sclerosis*
Systemic Vasculitis*
Vasculitis* / chemically induced
Vasculitis* / drug therapy

Substances

Antibodies, Antineutrophil Cytoplasmic
Alemtuzumab